Biotech
Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted
Shots: The companies collaborated to develop AAV vectors deploying Cure Genetics’ VELP platform to develop next-generation gene therapies The focus of the pact is to provide new AAV serotypes for […]readmore